Literature DB >> 23146912

Near-infrared spectroscopy can predict the onset of cerebral hyperperfusion syndrome after carotid endarterectomy.

C W A Pennekamp1, R V Immink, H M den Ruijter, L J Kappelle, C M Ferrier, M L Bots, W F Buhre, F L Moll, G J de Borst.   

Abstract

BACKGROUND: Cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) is a potential life-threatening complication. Therefore, early identification and treatment of patients at risk is essential. CHS can be predicted by a doubling of postoperative transcranial Doppler (TCD)-derived mean middle cerebral artery blood velocity (V(mean)) compared to preoperative values. However, in approximately 15% of CEA patients, an adequate TCD signal cannot be obtained due to an insufficient temporal bone window. Moreover, the use of TCD requires specifically skilled personnel. An alternative and promising technique of noninvasive cerebral monitoring is relative frontal lobe oxygenation (rSO(2)) measured by near-infrared spectroscopy (NIRS), which offers on-line information about cerebral oxygenation without the need for specialized personnel. In this study, we assess whether NIRS and perioperative TCD are related to the onset CHS following CEA.
METHODS: Patients who underwent CEA under general anesthesia and had a sufficient TCD window were prospectively included. The V(mean) and rSO(2) measured before induction of anesthesia were compared to measurements performed in the first postoperative hour (ΔV(mean), ΔrSO(2), respectively). Logistic regression analysis was performed to determine the relationship between ΔV and ΔrSO(2) and the occurrence of CHS. Subsequently, receiver operating characteristic (ROC) curve analysis was used to determine the optimal cutoff values. Diagnostic values were shown as positive and negative predictive values (PPV and NPV).
RESULTS: In total, 151 patients were included, of which 7 patients developed CHS. The ΔV(mean) and ΔrSO(2) differed between CHS and non-CHS patients (median, interquartile range), i.e. 74% (67-103) versus 16% (-2 to 41), p = 0.001, and 7% (4-15) versus 1% (-6 to 7), p = 0.009, respectively. The mean arterial blood pressure did not change. Postoperative ΔV(mean) and ΔrSO(2) were significantly related to the occurrence of CHS [odds ratio (OR) 1.40 (95% CI 1.02-1.93) per 30% increase in V(mean) and OR 1.82 (95% CI 1.11-2.99) per 5% increase in rSO(2)]. ROC curve analysis showed an area under the curve of 0.88 (p = 0.001) for ΔV(mean) and an optimal cutoff value of 67% increase (PPV 38% and NPV 99%), and an area under the curve of 0.79 (p = 0.009) for ΔrSO(2) and an optimal cutoff value of 3% rSO(2) increase (PPV 11% and NPV 100%). The combination of both monitoring techniques provided a PPV of 58% and an NPV of 99%.
CONCLUSIONS: Both TCD and NIRS measurements can be used to safely identify patients not at risk of developing CHS. It appears that NIRS is a good alternative when a TCD signal cannot be obtained.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23146912     DOI: 10.1159/000343229

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  18 in total

1.  Postendarterectomy Cerebral Hyperperfusion Syndrome: The Etiological Significance of "Cerebral Reserve".

Authors:  George L Hines; Donald DeCrosta; Sarah Kantaria; Chris Cary; Shahidul Islam
Journal:  Int J Angiol       Date:  2014-06-09

2.  Transcranial Optical Monitoring of Cerebral Hemodynamics in Acute Stroke Patients during Mechanical Thrombectomy.

Authors:  Rodrigo M Forti; Christopher G Favilla; Jeffrey M Cochran; Wesley B Baker; John A Detre; Scott E Kasner; Michael T Mullen; Steven R Messé; W Andrew Kofke; Ramani Balu; David Kung; Bryan A Pukenas; Neda I Sedora-Roman; Robert W Hurst; Omar A Choudhri; Rickson C Mesquita; Arjun G Yodh
Journal:  J Stroke Cerebrovasc Dis       Date:  2019-04-08       Impact factor: 2.136

3.  Hyperventilation and breath-holding test with indocyanine green kinetics predicts cerebral hyperperfusion after carotid artery stenting.

Authors:  Ichiro Nakagawa; Shohei Yokoyama; Daisuke Wajima; Fumihiko Nishimura; Shuichi Yamada; Hiroshi Yokota; Yasushi Motoyama; Young Su Park; Takeshi Wada; Kimihiko Kichikawa; Hiroyuki Nakase
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-17       Impact factor: 6.200

Review 4.  [Near-infrared spectroscopy : Technique, development, current use and perspectives].

Authors:  D Bolkenius; C Dumps; B Rupprecht
Journal:  Anaesthesist       Date:  2021-03       Impact factor: 1.041

5.  Near-infrared spectroscopy assessed cerebral oxygenation during open abdominal aortic aneurysm repair: relation to end-tidal CO2 tension.

Authors:  H Sørensen; H B Nielsen; N H Secher
Journal:  J Clin Monit Comput       Date:  2015-07-04       Impact factor: 2.502

6.  An unexpected reduction in the value of near-infrared spectroscopy in a child with moyamoya disease.

Authors:  Jayanth R Seshan; Indu Kapoor; Hemanshu Prabhakar; Charu Mahajan
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2022-02-14

Review 7.  Cerebral Hyperperfusion Syndrome After Carotid Revascularization and Acute Ischemic Stroke.

Authors:  Kathryn F Kirchoff-Torres; Ekaterina Bakradze
Journal:  Curr Pain Headache Rep       Date:  2018-03-19

8.  Noninvasive cerebral oximetry during endovascular therapy for acute ischemic stroke: an observational study.

Authors:  Christian Hametner; Predrag Stanarcevic; Sibylle Stampfl; Stefan Rohde; Roland Veltkamp; Julian Bösel
Journal:  J Cereb Blood Flow Metab       Date:  2015-08-05       Impact factor: 6.200

Review 9.  Monitoring of brain and systemic oxygenation in neurocritical care patients.

Authors:  Mauro Oddo; Julian Bösel
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

10.  Forehead Regional Oxygen Saturation (rSO2)-Related Ear-Level Arterial Pressure and Lower Thigh rSO2 in the Steep Trendelenburg Position with CO2 Pneumoperitoneum and the Beach Chair Position.

Authors:  Tomoko Fukada; Yuri Tsuchiya; Hiroko Iwakiri; Makoto Ozaki; Minoru Nomura
Journal:  Cureus       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.